Search engine for other government resources
LiverTox - NCBI BookshelfLiverTox provides up-to-date, unbiased and easily accessed information on the diagnosis, cause, frequency, clinical patterns and management of liver ...www.ncbi.nlm.nih.gov/books/NBK547852/ Safety and efficacy of COVID-19 vaccines in multiple ...Alemtuzumab is a humanized MAB that targets CD52 receptors on the surface of lymphocytes, causing generalized lymphopenia with a more pronounced ...www.ncbi.nlm.nih.gov/pmc/articles/PMC8095041/ Warm antibody autoimmune hemolytic anemiaAlemtuzumab: 3 mg intravenously or subcutaneously on day 1 and then if tolerated, 10 mg on day 2, and then if tolerated, 30 mg on day 3, continue with ...www.ncbi.nlm.nih.gov/pmc/articles/PMC6142448/ Drugs and Lactation Database LactMed - NCBI BookshelfThe LactMed database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. It includes information on the ...www.ncbi.nlm.nih.gov/books/NBK501922/ Long-term Survival in Head and Neck Cancer Impact of Site ...Objectives/hypothesis: Literature examining long-term survival in head and neck squamous cell carcinoma (HNSCC) with human papillomavirus (HPV) status ...pubmed.ncbi.nlm.nih.gov/30637762/ Transverse Myelitis Fact Sheet National Institute of ...Multiple sclerosis and neuromyelitis optica typically require long-term treatment to modify the immune system response. Treatment of MS with ...www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Transverse-Myelitis-Fact-Sheet 
DrugsFDA FDA-Approved Drugs* Drugs@FDA includes information about drugs, including biological products, approved for human use in the United States (see FAQ), but does not ...www.accessdata.fda.gov/scripts/cder/daf/ Vaccine Booster FAQ - Queens Health Systems COVID-19 ...Other biologic agents that are immunosuppressive or immunomodulatory (thymoglobulin, alemtuzumab, rituximab) Medical Conditions with Varied ...covid.queens.org/vaccine-booster-faq/ Chemotherapy Drug Information Chemocare.comC225 Cabazitaxel Cablivi Cabozantinib Calcium Leucovorin Calquence Campath Camptosar Camptothecin-11 Capecitabine Caplacizumab-yhdp Capmatinib ...chemocare.com/chemotherapy/drug-info/default.aspx Login{{ $t("message.login.invalid.title") }} {{ $t("message.login.invalid.text") }} {{ $t("message.common.username") }}online.lexi.com/crlsql/servlet/crlonline Monoclonal Antibodies - National Cancer InstituteMonoclonal antibodies can cause side effects, which can differ from person to person. The ones you may have and how they make you feel will depend on ...www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies COVID-19 Vaccine - Penn MedicineAlemtuzumab (e.g. Lemtrada) Eculizumab (e.g., Soliris) We are scheduling third vaccine dose appointments for severely immunocompromised patients at ...www.pennmedicine.org/coronavirus/vaccine
Mayo Clinic LaboratoriesMedical reference laboratory providing esoteric and genetic testing services, test selection guidance, result interpretation references, and ...www.mayocliniclabs.com/ National Institute for Occupational Safety Health ...The Occupational Safety and Health Act of 1970 established NIOSH as a research agency focused on the study of worker safety and health, and empowering ...www.cdc.gov/niosh/index.htm Drugs.com Prescription Drug Information Interactions ...Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent ...www.drugs.com/ PDF HIGHLIGHTS OF PRESCRIBING INFORMATION PD-L1 Combined ...MSI-H Cancer: 200 mg every 3 weeks for adults and 2 mg/kg (up to 200 mg) every 3 weeks for pediatrics. (2.9) Gastric Cancer: 200 mg every 3 weeks.www.accessdata.fda.gov/drugsatfda_docs/label/2020/125514s066lbl.pdf Medications that suppress the immune system Yale HealthMedications that suppress the immune system. Taking high-dose corticosteroids (equal to at least 20 mg of prednisone daily) or any of the other ...yalehealth.yale.edu/medications-suppress-immune-system Risk Evaluation and Mitigation Strategies REMS FDAA Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program that the U.S. Food and Drug Administration (FDA) can require for certain ...www.fda.gov/drugs/drug-safety-and-availability/risk-evaluation-and-mitigation-strategies-rems
RxList - The Internet Drug Index for prescription drug ...Medications and prescription drug information for consumers and medical health professionals. Online database of the most popular drugs and their side ...www.rxlist.com/ Burning Legs Causes Treatments and SymptomsCauses of burning legs. A burning sensation in your legs may have an obvious explanation, like a leg injury or during or after intense exercise.It ...www.healthline.com/health/burning-legs |